| Jan 15 2021 |
Privacy and Data Protection – India Wrap 2020 |
Nishith Desai Associates |
| Jan 15 2021 |
Relaxations for AIFs in GIFT City |
Nishith Desai Associates |
| Jan 15 2021 |
Are Tenant-Landlord Disputes Arbitrable? Supreme Court of India Overturns its Own Judgement |
Nishith Desai Associates |
| Jan 12 2021 |
Regulatory Yearly Wrap 2020: Medical Device in India |
Nishith Desai Associates |
| Jan 11 2021 |
Regulatory Yearly Wrap 2020: Healthcare in India |
Nishith Desai Associates |
| Jan 11 2021 |
Regulatory Yearly Wrap 2020: Pharmaceuticals In India |
Nishith Desai Associates |
| Jan 8 2021 |
Indian High Court Denies Tax Exemption on Corporate Gift – Holds Share Transfer without ‘Voluntariness’ not Valid Gift |
Nishith Desai Associates |
| Jan 8 2021 |
Valuation of AIFS in India VS Funds in the US |
Nishith Desai Associates |
| Jan 8 2021 |
Cairn V. India - Investment Treaty Arbitration |
Nishith Desai Associates |
| Dec 28 2020 |
Healthcare Law and Policy in India – Analysis of Where We Are and Where We Are Going [Podcast] |
Nishith Desai Associates |
| Dec 27 2020 |
Digital Health in India: Emerging Technologies (AI and 3D printing) [Podcast] |
Nishith Desai Associates |
| Dec 26 2020 |
Digital Health in India: Online Pharmacies and Telemedicine [Podcast] |
Nishith Desai Associates |
| Dec 25 2020 |
Intellectual Property Issues in the Indian Pharmaceutical Sector: Patents |
Nishith Desai Associates |
| Dec 24 2020 |
Advertisement and Promotion of Drugs and Medical Devices to Healthcare Practitioners in India |
Nishith Desai Associates |
| Dec 23 2020 |
January 2021 Visa Bulletin – Small Advancements Continue |
Hunton Andrews Kurth |
| Dec 23 2020 |
Direct to Consumer Advertisement and Promotion of Drugs and Medical Devices in India [Podcast] |
Nishith Desai Associates |
| Dec 22 2020 |
Regulating the Prices of Drugs and Medical Devices in India: A Legal and Policy Perspective |
Nishith Desai Associates |
| Dec 21 2020 |
Launching a Drug or Medical Device in India: From Clinical Trial to Sale [PODCAST} |
Nishith Desai Associates |
| Dec 19 2020 |
Indian Pharmaceutical and Medical Device Regulation 101 [PODCAST] |
Nishith Desai Associates |
| Dec 18 2020 |
Introduction to the Pharma & Healthcare Podcast Series [PODCAST] |
Nishith Desai Associates |
| Dec 6 2020 |
Liability for Investment Committee Members of an AIF - Excessive or Necessary? |
Nishith Desai Associates |
| Dec 6 2020 |
High Court in India Reaffirms the Need for an Individual’s ‘Right to Be Forgotten’ |
Nishith Desai Associates |
| Nov 30 2020 |
India: Foreign Contribution Rules Amended to Further Tighten Foreign Contribution Norms |
Nishith Desai Associates |
| Nov 30 2020 |
India: Intersection of Private International Law and Taxation: Bombay High Court Applies Lex Domicilii Rule in Tax Matters |
Nishith Desai Associates |
| Nov 20 2020 |
India: Liberalized Regime for Business Outsourcing Services |
Nishith Desai Associates |
| Nov 20 2020 |
Securities Exchange Board of India (SEBI) Introduces New AIF Investment Committee Regulations |
Nishith Desai Associates |
| Nov 19 2020 |
The Campus in Campus Model for Foreign Universities in India |
Nishith Desai Associates |
| Nov 18 2020 |
India: AAR Applies the ‘look Through’ Approach – Denies Treaty Relief to a Mauritian Entity on Transfer of Indian Shares |
Nishith Desai Associates |
| Nov 18 2020 |
India: Patent (Amendment) Rules, 2020: Streamlining Form 27 Filings |
Nishith Desai Associates |
| Nov 17 2020 |
India: Issues and Aspects Concerning Leverage by Category III AIFS |
Nishith Desai Associates |
| Nov 17 2020 |
India: Term, Termination and Liquidation of an Alternative Investment Funds (Aif) |
Nishith Desai Associates |
| Nov 17 2020 |
Permanent Establishment: Scope of Preliminary and Auxiliary Activities |
Nishith Desai Associates |
| Nov 12 2020 |
India: Signatory or Not – a Group of Companies Can Be Referred to Arbitration |
Nishith Desai Associates |
| Nov 12 2020 |
India: Incentivising Category-III AIFs in the IFSC |
Nishith Desai Associates |
| Nov 11 2020 |
India: Exchange of Shares as Stock-In-Trade in an Amalgamation to Be Taxable |
Nishith Desai Associates |
